Ex-GV partner Eze Vidra has joined Kevin E. Baxpehler, formerly of ProSiebenSat.1, to set up a corporate-backed media fund that is raising $40m.

Restaurant management device developer Salido increased its funding to $16m with a round featuring strategic partner First Data.

NewYork-Presbyterian Hospital was among the backers in a round that took the healthcare planning platform's total funding to more than $43m.

Oriola took a 17% stake in the corporate health services startup through through the round, having already been a strategic partner.

Lilly Asia Ventures and Sinopharm Healthcare Fund co-led the round that will fund a phase 3 trial for Ansun Biopharma's parainfluenza treatment.

Johnson & Johnson, Vactech and MacroGenics all own stakes in Provention they got through licensing drug candidates to the company.

Beam, a genetic medicine developer in which Editas Medicine is a shareholder, has emerged from stealth with an $87m series A round.

Renaissance Venture Capital Fund has closed its third fund of funds at $81m, securing several Michigan-based corporates as limited partners.

Existing backer Rakuten Ventures co-led a series C round for the used goods e-commerce platform, bringing its total funding to $127m.

NUS spinout MediSix has obtained $20m from investors including Osage University Partners to commercialise research into leukaemia and lymphoma treatments.